Clinical Trials | March 14, 2026
Gesynta Pharma launches Phase 2 trial of promising Endometriosis drug
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
The new facilities are designed to provide focused, patient-centric care through advanced diagnostics, minimally invasive treatments, and multidisciplinary expertise
Doctors recommended a robotic Strassmann Metroplasty, a reconstructive surgery that joins the two halves of the uterus into a single cavity capable of supporting pregnancy
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
This marks the fourth acquisition by Corona Remedies from multinational corporations
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
Our centers are performing as expected or even better
Subscribe To Our Newsletter & Stay Updated
